<html><head></head><body><h1>Organidin NR</h1><p class="drug-subtitle"><b>Generic Name:</b> guaifenesin<br/>
<b>Dosage Form:</b> tablet<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Side Effects</li>
<li>Dosage</li>
<li><b class="nav-item here">Professional</b></li>
<li>Pregnancy</li>
<li>Breastfeeding</li>
<li>Images</li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.</p><ul>
<li>Description</li>
<li>Clinical Pharmacology</li>
<li>Indications and Usage</li>
<li>Contraindications</li>
<li>Precautions</li>
<li>Adverse Reactions/Side Effects</li>
<li>Overdosage</li>
<li class="ddc-toggle-hidden">Dosage and Administration</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
</ul><p>The Organidin NR brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.</p><h2>Organidin NR Description</h2><p class="First">Guaifenesin (glyceryl guaiacolate) has the chemical name 3-(2-methoxyphenoxy)-1,2-propanediol. Its molecular formula is C<span class="Sub">10</span>H<span class="Sub">14</span>O<span class="Sub">4</span> with a molecular weight of 198.21. It is a white or slightly gray crystalline substance with a slightly bitter aromatic taste. One gram dissolves in 20 mL water at 25°C; it is freely soluble in ethanol. Guaifenesin is readily absorbed from the GI tract and is rapidly metabolized and excreted in the urine. Guaifenesin has a plasma half-life of one hour. The major urinary metabolite is β-(2-methoxyphenoxy) lactic acid.</p><p>ORGANIDIN<span class="Sup">®</span> NR (guaifenesin) is an expectorant available for oral administration as:</p><p><span class="Bold">Tablets —</span> each containing 200 mg guaifenesin, USP.</p><p><span class="Italics">Other ingredients:</span> Corn starch, croscarmellose sodium, FD&amp;C Red No. 40, magnesium stearate, microcrystalline cellulose.</p><h2>Organidin NR - Clinical Pharmacology</h2><p class="First">ORGANIDIN<span class="Sup">®</span> NR (guaifenesin) is an expectorant, the action of which promotes or facilitates the removal of secretions from the respiratory tract. By increasing sputum volume and making sputum less viscous, guaifenesin facilitates expectoration of retained secretions.</p><h2>Indications and Usage for Organidin NR</h2><p class="First">ORGANIDIN<span class="Sup">®</span> NR: Helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus, drain bronchial tubes and make coughs more productive. Helps loosen phlegm and thin bronchial secretions in patients with stable chronic bronchitis.</p><h2>Contraindications</h2><p class="First">Hypersensitivity to any of the ingredients.</p><h2>Precautions</h2><p class="First"><span class="Italics">Carcinogenesis, Mutagenesis, Impairment of Fertility:</span> Animal studies to assess the long-term carcinogenic and mutagenic potential or the effect on fertility in animals or humans have not been performed.</p><p class="First"><span class="Italics">Pregnancy:</span></p><p class="First"><span class="Italics">Teratogenic Effects—Pregnancy Category C:</span> Animal reproduction studies have not been conducted. Safe use in pregnancy has not been established relative to possible adverse effects on fetal development. Therefore, these products should not be used in pregnant patients unless, in the judgment of the physician, the potential benefits outweigh possible hazards.</p><p class="First"><span class="Italics">Nursing Mothers:</span> It is not known whether guaifenesin is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when these products are administered to a nursing woman and a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.</p><p class="First"><span class="Italics">Laboratory Test Interactions:</span> Guaifenesin or its metabolites may cause color interference with the VMA (vanillylmandelic acid) test for catechols. It may also falsely elevate the level of urinary 5-HIAA (5-hydroxyindoleacetic acid) in certain serotonin metabolite chemical tests because of color interference.</p><h2>Adverse Reactions</h2><p class="First"><span class="Bold">To report SUSPECTED ADVERSE REACTIONS, contact Meda Pharmaceuticals Inc. at 1-800-526-3840 or FDA at 1-800-FDA-1088 or <span class="Italics Underline">www.fda.gov/medwatch</span>.</span></p><p><span class="Bold">Guaifenesin</span> is well tolerated and has a wide margin of safety. Side effects have been generally mild and infrequent. Nausea and vomiting are the side effects that occur most commonly. Dizziness, headache, and rash (including urticaria) have been reported rarely.</p><h2>Overdosage</h2><p class="First">In massive overdosage the stomach should be emptied (emesis and/or gastric lavage) and further absorption prevented. Treatment is symptomatic and supportive.</p><p>The acute toxicity of <span class="Bold">guaifenesin</span> is low and overdosage is unlikely to produce serious toxic effects. In laboratory animals no toxicity resulted when guaifenesin was administered by stomach tube in doses up to 5 grams/kg.</p><h2>Organidin NR Dosage and Administration</h2><p class="First">ORGANIDIN<span class="Sup">®</span> NR (guaifenesin)</p><p><span class="Italics">Tablets — Adults and children 12 years of age and older:</span> One to 2 tablets (200 mg to 400 mg) every four hours, not to exceed 2400 mg (12 tablets) in 24 hours.</p><p>PATIENTS SHOULD BE ADVISED TO KEEP THESE AND ALL DRUGS OUT OF THE REACH OF CHILDREN AND TO SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY IN CASE OF ACCIDENTAL OVERDOSE.</p><h2>How is Organidin NR Supplied</h2><p class="First">ORGANIDIN<span class="Sup">®</span> NR (guaifenesin)</p><p><span class="Italics">Tablets</span> — Each round, scored, rose-colored tablet contains 200 mg guaifenesin USP—available in bottles of 100 (NDC 0037-4312-01)</p><p class="First"><span class="Bold">STORAGE</span> — Store at controlled room temperature 20°-25°C (68°-77°F). Protect tablets from moisture. Keep bottle tightly closed.</p><p><span class="Bold">To report SUSPECTED ADVERSE REACTIONS, contact Meda Pharmaceuticals Inc. at 1-800-526-3840 or FDA at 1-800-FDA-1088 or <span class="Italics Underline">www.fda.gov/medwatch</span>.</span></p><p><span class="Bold">MEDA PHARMACEUTICALS<br/>
Meda Pharmaceuticals Inc.</span><br/>
Somerset, New Jersey 08873-4120</p><p>IN-046J2-08           Rev. 11/09</p><p class="First"><span class="Bold">Package Label - Principal Display Panel – 100 Tablet Bottle, Organidin NR Tablets</span><br/>
<br/>
NDC 0037-4312-01<br/>
<span class="Bold">100 Tablets<br/>
Organidin<span class="Sup">®</span> NR<br/>
Tablets (guaifenesin)<br/>
Expectorant<br/>
Each tablet<span class="Sup">§</span> contains:<br/>
Guaifenesin USP     200 mg</span><br/>
Other ingredients: croscarmellose sodium,<br/>
FD&amp;C Red #40, magnesium stearate,<br/>
microcrystalline cellulose, starch.<br/>
<span class="Sup">§</span>Assayed by a procedure other than that<br/>
specified in the USP.<br/>
<span class="Bold">This product labeled for dispensing on<br/>
prescription only.<br/>
Meda<br/>
Pharmaceuticals<span class="Sup">®</span></span><br/>
LB-046J2-06         Rev. 1/09<br/>
See package insert for dosing<br/>
information and directions for use.<br/>
Store at controlled room<br/>
temperature 20°-25°C<br/>
(68°-77°F).<br/>
Protect from moisture.<br/>
Dispense in tight container.<br/>
Meda Pharmaceuticals<span class="Sup">®</span><br/>
Meda Pharmaceuticals Inc.<br/>
Somerset, New Jersey 08873-4120</p><p></p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What is the dose for an adult for Robitussin DM? How many times a day?</li>
</ul><h2>More about Organidin NR (guaifenesin)</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug class: expectorants</li>
<li>FDA Alerts (4)</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li>Guaifenesin Tablets &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Bronchiectasis</li>
<li>Bronchitis</li>
<li>Cough</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>